East African Health Publications & Thesis Hub

Welcome to Universal Health Thesis & Publications Hub: open and free access to quality thesis, peer reviewed articles and policy documents.



INTERIM GUIDELINES ON MANAGEMENT OF COVID-19 IN KENYA

Authors

Ministry of Health,Kenya

Abstract

Coronavirus disease 2019 (COVID-19) is an acute respiratory infection caused by severe acute respiratory syndrome coronavirus 2 (SARSCoV-2). SARS-CoV-2 belongs to the Sarbecovirus subgenus of the Coronaviridae family, and is the seventh coronavirus known to infect humans.

Coronaviruses are a large family of enveloped RNA viruses, some of which cause illness in people (e.g., common cold, SARS, MERS), and others that circulate among mammals (e.g., bats, camels) and birds. Rarely, animal coronaviruses can spread to humans and subsequently spread between humans. Similar to SARS and MERS, it is thought that human transmission occurs via respiratory droplets produced when a person sneezes or coughs.

Current estimates of the incubation period range from 1 to 14 days, according to the World Health Organization. The average incubation period is currently estimated to be 5 days. Transmission can occur during the incubation period. The most common clinical presentation is that of a respiratory infection with a symptom severity ranging from a mild common cold-like illness (estimated 80% of cases), to a severe viral pneumonia leading to acute respiratory distress syndrome that is potentially fatal.

WHO first declared COVID-19 to be a public health emergency of international concern on 30 January 2020 and subsequently declared it a pandemic on 11 March 2020. The first confirmed case in Kenya was reported on 13th March 2020 

 

Document details

ID:UH2030-140
Year:2020
Volume:
Issue:
ISBN:
Document Type:Policy Documents
Health Topic:Clinical Guidelines
Downloaded38 times
KeywordsCOVID-19 , Treatment guideline, , Coronavirus, , Case management,
Access this Publication Updated-Case-Management-Guidelines-26_03_20-1.pdf

FIND US ON FACEBOOK

FIND US ON TWITTER